The Schedule of Pharmaceutical Benefits was updated on 1 May 2019 and the Summary of Changes can be found on the New, Amended and Deleted Items page. A number of updates are now also available via the PBS website.
The following updates have are now available:
- Formulary Allocations - 1 May 2019
- Ex-manufacturer price - 1 May 2019
- Drugs subject to Price Disclosure - 1 May 2019
- PBAC Cycle Timeframe for 2019 - 2020
- Drugs and manners of administration that meet the 30 month clock (for an originator removal calculation) for the 2019 October Cycle
- Drugs and manners of administration that meet the 42 month clock (for a 30% Unadjusted Price Reduction) for the 2019 October Cycle
- PBS and RPBS Section 85 Date of Supply Data
- AMWG Comparator Selection Subgroup Communique
- Generic Medicines Working Group (GMWG) Communique
- The Closing the Gap - PBS Co-payment Measure
- Pharmaceutical Benefits Advisory Committee (PBAC) Membership
- Guarantee of supply
- Recommendations made by the PBAC - March 2019 - 26 April 2019
- PD-L(1) checkpoint inhibitor Stakeholder Meeting Outcome Statement - 12 April 2019
- Public Consultation – PBS Process Improvements Stage 1 - 10 April 2019
- 1 April 2019 Price Disclosure Confirmed Prices - 1 April 2019
- Correction for Venetoclax restriction - 1 April 2019
- Notification regarding restrictions for Nilotinib item 9171Q - nilotinib 200 mg capsule, 120 (Tasigna, NV) - 1 April 2019